|
| 37584291 | Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome. | Haematologica | 2024 |
| 36586540 | Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency. | Gastroenterology | 2023 |
| 37931683 | Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous. | | 2023 |
| 38010733 | Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway. | | 2023 |
| 37628315 | Telehealth Needs and Concerns of Stakeholders in Pediatric Palliative Home Care. | | 2023 |
| 37548393 | Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group. | | 2023 |
| 37159273 | Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors. | | 2023 |
| 35347251 | Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics? | Modern Pathology | 2022 |
| 35698215 | Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up. | BMC Cancer | 2022 |
| 35802025 | FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits. | Cancer Res | 2022 |
| 36575299 | Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. | NPJ Precis Oncol | 2022 |
| 34762643 | DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma. | PLoS Comput Biol | 2021 |
| 32179705 | Germline <i>RET</i> variants underlie a subset of paediatric osteosarcoma. | J Med Genet | 2021 |
| 33963544 | The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies. | J Pathol | 2021 |
| 33084925 | [Erratum to: DKG certification of paediatric cancer centres - a wide field ⿦]. | Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz | 2021 |
| 33295144 | Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target? | J Pathol Clin Res | 2021 |
| 34373263 | The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets. | Cancer Discov | 2021 |
| 31431735 | Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. | Leukemia | 2020 |
| 32022484 | NTRK fusions in osteosarcoma are rare and non-functional events. | J Pathol Clin Res | 2020 |
| 32362894 | Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment. | Front Immunol | 2020 |
| 31928458 | Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. | J Clin Oncol | 2020 |
| 31494577 | High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers. | Journal of Medical Genetics | 2020 |
| 30740824 | A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes. | Hum Mutat | 2019 |
| 31738425 | Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. | Annals of Oncology | 2019 |
| 32223937 | Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. | Annals of Oncology | 2019 |
| 30549028 | Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone. | J Pathol | 2019 |
| 29755686 | Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy. | Oncotarget | 2018 |
| 30013564 | No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. | Front Immunol | 2018 |
| 29489754 | The landscape of genomic alterations across childhood cancers. | Nature | 2018 |
| 28168833 | Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. | Am J Med Genet A | 2017 |
| 28494505 | Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma. | International Journal of Cancer | 2017 |
| 29152092 | The long non-coding RNA is associated with and the absence of FRA16D breakage in osteosarcoma patients. | Oncotarget | 2017 |
| 27447864 | Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics. | Oncotarget | 2017 |
| 28196983 | Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis. | Leukemia | 2017 |
| 27569442 | Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. | Lancet Oncol | 2016 |
| 27099149 | Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome. | Blood | 2016 |
| 27315524 | The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. | Clin Sarcoma Res | 2016 |
| 27479119 | Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study. | Eur J Cancer | 2016 |
| 26632267 | Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. | Nat Commun | 2015 |
| 25848766 | Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules. | PLoS One | 2015 |
| 25672644 | Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected]. | Journal of Neuro-Oncology | 2015 |
| 25762628 | TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome. | Oncotarget | 2015 |
| 26039064 | New small molecules targeting apoptosis and cell viability in osteosarcoma. | PLoS One | 2015 |
| 26037465 | Erratum to: Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity. | Journal of Neuro-Oncology | 2015 |
| 24955218 | Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma - reasons and consequences. | Genes and Cancer | 2014 |
| 24246156 | Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK Registry. | Oral Oncology | 2014 |
| 24417819 | Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. | Gastroenterology | 2014 |
| 24865352 | Structuring osteosarcoma knowledge: an osteosarcoma-gene association database based on literature mining and manual annotation. | Database (Oxford) | 2014 |
| 25092376 | A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice. | Molecular Cancer | 2014 |
| 23169501 | Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. | Journal of Clinical Oncology | 2013 |